Deep Dive: Deep Dive Into Aducanumab’s Appropriate Use Criteria

Dr. Alireza Atri, the director of the Banner Sun Health Research Institute in Sun City, AZ, joined Deep Dive from the floor of the 2021 Alzheimer’s Association International Conference to discuss the recently published and presented Appropriate Use Criteria for aducanumab, or Aduhelm, Biogen’s newly approved anti-amyloid agent for the treatment of Alzheimer’s disease.